Infant Bacterial Therapeutics AB
Developing novel biotherapeutics for premature infant diseases through rigorous clinical trials.
Oversigt
- 5–9
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2011
- Grundlagt
Nøglebeslutningstagere
Staffan Strömberg
Chief Executive Officer
Sanjiv Sharma
Head of Medical Affairs
Margareta Hagman
Board Member
Sebastian Jahreskog
Member of the Nominating Committee
+11 flere kontakter i Funnelfeedr
Beskrivelse
Infant Bacterial Therapeutics AB (IBT) is a specialized pharmaceutical company focused on developing and commercializing novel drugs specifically targeting diseases affecting premature infants. The company addresses significant unmet medical needs, such as Necrotizing Enterocolitis (NEC), gastroschi...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556873858601
Beslutningstagere
15 kontakter i FunnelfeedrStaffan Strömberg
Chief Executive Officer
Sanjiv Sharma
Head of Medical Affairs
Margareta Hagman
Board Member
Sebastian Jahreskog
Member of the Nominating Committee
David Dangoor
Chairman of the Nominating Committee
Anders Kronström
Chief Operating Officer
Eva Idén
Board Member
Anthon Jahreskog
Board Member
Maria Ekdahl
Chief Financial Officer
Jannis Kitsakis
Member of the Nominating Committee
Peter Rothschild
Chairman of the Board
Thomas J. Schnitzer
Chief Scientific Officer
Kristina Sjöblom Nygren
Board Member
Andre kontakter
Nigel Titford
Press Contact
Josef Neu
Medical Advisor Neonatology
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
BioGaia Pharma AB
0 medarbejdereDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
iCoat Medical AB
1–4 medarbejdereDeveloping drugs to improve organ transplantation outcomes globally.
Disruptive Pharma AB (publ)
5–9 medarbejdereSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
OxThera Intellectual Property AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
iCoat Medical Operations AB
Developing drugs to improve organ transplantation outcomes globally.
Udforsk mere
Spørgsmål om Infant Bacterial Therapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo